Lymphadenopathy Associated With the COVID-19 Vaccine-Reference-Cited by-同舟云学术

Lymphadenopathy Associated With the COVID-19 Vaccine

Published:2021-02-23 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Hiller Nurith,Goldberg Shraga Nahum,Cohen-Cymberknoh Malena,Vainstein Vladimir,Simanovsky Natalia

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference6 articles.

1. Messenger RNA-based vaccines against infectious diseases [Online ahead of print];Alameh MG;Curr Top Microbiol Immunol,2020

2. mRNA as a transformative technology for vaccine development to control infectious diseases;Maruggi G;Mol Ther,2019

3. Advances in mRNA vaccines for infectious diseases;Zhang C;Front Immunol,2019

4. Fact sheet for recipients and caregivers. emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 16 years of age and older. (2020). Accessed: January 31, 2021: https://www.fda.gov/media/144414/download.

5. Defending against smallpox: a focus on vaccines;Voigt EA;Expert Rev Vaccines,2016

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy;European Journal of Clinical Investigation;2024-08-08

2. Peripheral lymphadenopathy of unknown origin in adults: a diagnostic approach emphasizing the malignancy hypothesis;Swiss Medical Weekly;2024-07-31

3. Prolonged febrile illness following first dose of ChAdOx1;BMJ Case Reports;2023-08

4. Axillary Lymph Nodes in Breast Cancer Patients After COVID-19 Vaccine;Indian Journal of Surgery;2023-05-13

5. Side effects of COVID-19 vaccinations in patients treated for breast cancer;Clinical and Experimental Medicine;2023-04-08